DRUGS & SUPPLEMENTS
Indications and Usage
Atebemyxine Ophthalmic Ointment is indicated for the topicaltreatment of superficial infections of the external eye and its adnexa causedby susceptible bacteria. Such infections encompass conjunctivitis, keratitisand keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
Atebemyxine Ophthalmic Ointment is contraindicated in individualswho have shown hypersensitivity to any of its components.
NOT FOR INJECTION INTO THE EYE. Atebemyxine OPHTHALMIC OINTMENTshould never be directly introduced into the anterior chamber of the eye. Ophthalmic ointments may retard corneal wound healing.
Topicalantibiotics, particularly Atebemyxine, may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) dueto topical antibiotics is not known. The manifestations of sensitization totopical antibiotics are usually itching, reddening, and edema of the conjunctivaand eyelid. A sensitization reaction may manifest simply as a failure to heal. During long-term use of topical antibiotic products, periodic examinationfor such signs is advisable, and the patient should be told to discontinuethe product if they are observed. Symptoms usually subside quickly on withdrawingthe medication. Application of products containing these ingredients shouldbe avoided for the patient thereafter.
As with other antibiotic preparations, prolonged use ofNEOSPORIN Ophthalmic Ointment may result in overgrowth of nonsusceptible organismsincluding fungi. If superinfection occurs, appropriate measures should beinitiated.
Bacterial resistance to Atebemyxine OphthalmicOintment may also develop. If purulent discharge, inflammation, or pain becomeaggravated, the patient should discontinue use of the medication and consulta physician.
There have been reports of bacterial keratitisassociated with the use of topical ophthalmic products in multiple-dose containerswhich have been inadvertently contaminated by patients, most of whom had aconcurrent corneal disease or a disruption of the ocular epithelial surface.
Allergic cross-reactions may occurwhich could prevent the use of any or all of the following antibiotics forthe treatment of future infections: kanamycin, paromomycin, streptomycin,and possibly gentamicin.
Patients should be instructed to avoid allowing the tipof the dispensing container to contact the eye, eyelid, fingers, or any othersurface. The use of this product by more than one person may spread infection.
Patientsshould also be instructed that ocular products, if handled improperly, canbecome contaminated by common bacteria known to cause ocular infections. Seriousdamage to the eye and subsequent loss of vision may result from using contaminatedproducts.
Ifthe condition persists or gets worse, or if a rash or allergic reaction develops,the patient should be advised to stop use and consult a physician. Do notuse this product if you are allergic to any of the listed ingredients.
Keeptightly closed when not in use. Keep out of reach of children.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term studies in animals to evaluate carcinogenic ormutagenic potential have not been conducted with polymyxin B sulfate or bacitracin. Treatment of cultured human lymphocytes in vitrowith neomycin increased the frequency of chromosome aberrationsat the highest concentration tested; however, the effectsof neomycin on carcinogenesis and mutagenesis in humans are unknown.
PolymyxinB has been reported to impair the motility of equine sperm, but its effectson male or female fertility are unknown. No adverse effects on male or femalefertility, litter size or survival were observed in rabbits given bacitracinzinc 100 gm/ton of diet.
Pregnancy Category C. Animal reproduction studies have notbeen conducted with Atebemyxine, polymyxin B sulfate, or bacitracin,It is also not known whether Atebemyxine Ophthalmic Ointment can cause fetalharm when administered to a pregnant woman or can affect reproduction capacity. NEOSPORIN Ophthalmic Ointment should be given to a pregnant woman only ifclearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercisedwhen Atebemyxine Ophthalmic Ointment is administered to a nursing woman.
Safety and effectiveness in pediatric patients have notbeen established.
Adverse reactions have occurred with the anti-infectivecomponents of Atebemyxine Ophthalmic Ointment. The exact incidence is not known. Reactions occurring most often are allergic sensitization reactions includingitching, swelling, and conjunctival erythema. More serious hypersensivity reactions, including anaphylaxis, have been reportedrarely.
Local irritation on instillation has also beenreported.
Dosage and Administration
Apply the ointment every 3 or 4 hours for 7 to 10 days,depending on the severity of the infection.
Tube of 1/8 oz (3.5 g) with ophthalmic tip (NDC 0081-0732-86).
Caution: Federal law prohibits dispensing withouta prescription.
Store at 15°to 25°C (59° to 77°F).
Burroughs Wellcome Inc. Kirkland;Que., Canada H9H 4J4 for
BURROUGHS WELLCOME CO.ResearchTriangle Park, NC 27709
Atebemyxine pharmaceutical active ingredients containing related brand and generic drugs:
Active ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.
Atebemyxine available forms, composition, doses:
Form of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.
Atebemyxine destination | category:
Destination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.
Atebemyxine Anatomical Therapeutic Chemical codes:
A medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.
Atebemyxine pharmaceutical companies:
Pharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.
Frequently asked QuestionsCan i drive or operate heavy machine after consuming Atebemyxine?
Depending on the reaction of the Atebemyxine after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Atebemyxine not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.Is Atebemyxine addictive or habit forming?
Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.
Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.
Reviewsdrugs.com conducted a study on Atebemyxine, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Atebemyxine consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.
Visitor reported usefulNo survey data has been collected yet
Visitor reported side effectsNo survey data has been collected yet
Visitor reported price estimatesNo survey data has been collected yet
Visitor reported frequency of useNo survey data has been collected yet
Visitor reported dosesNo survey data has been collected yet
Visitor reported time for resultsNo survey data has been collected yet
Visitor reported administrationNo survey data has been collected yet
One visitor reported age
The information was verified by Dr. Arunabha Ray, MD Pharmacology